Gracell Biotechnologies (GRCL) Earnings Date, Estimates & Call Transcripts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesOwnershipShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGRCL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GRCL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyNvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.To see Porter Stansberry's new AI prediction go here now. Gracell Biotechnologies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.92) EPSNext Year EPS Consensus Estimate: ($0.97) EPS Gracell Biotechnologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/13/2023Q3 2023($0.26)($0.10)+$0.16($0.10)--8/14/2023Q2 2023($0.37)($0.30)+$0.07($0.30)--5/15/2023Q1 2023($0.35)($0.35)-($0.35)--3/13/2023Q4 2022($0.43)($0.30)+$0.13($0.30)-- 11/14/2022Q3 2022($0.09)($0.36)($0.27)($0.36)-- 8/15/2022Q2 2022($0.08)($0.32)($0.24)($0.32)-- Get the Latest News and Ratings for GRCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gracell Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($0.08)($0.37)($0.29)($0.37)-- 3/14/2022Q4 2021($0.38)($0.30)+$0.08($0.30)-- 11/14/2021Q3($0.12)($0.30)($0.18)($0.06)-$0.06 million8/16/2021Q2 2021($0.12)($0.20)($0.08)($0.22)-- 5/16/2021Q1($0.2130)($0.25)($0.0370)($0.25)--3/8/2021Q4($0.27)($0.16)+$0.11--- Gracell Biotechnologies Earnings - Frequently Asked Questions How much revenue does Gracell Biotechnologies generate each year? Gracell Biotechnologies (NASDAQ:GRCL) has a recorded annual revenue of $60,000.00. How much profit does Gracell Biotechnologies generate each year? Gracell Biotechnologies (NASDAQ:GRCL) has a recorded net income of -$88.08 million. GRCL has generated -$1.05 earnings per share over the last four quarters. What is Gracell Biotechnologies's EPS forecast for next year? Gracell Biotechnologies's earnings are expected to decrease from ($0.92) per share to ($0.97) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Allogene Therapeutics Earnings Date Poseida Therapeutics Earnings Date bluebird bio Earnings Date LianBio Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (NASDAQ:GRCL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gracell Biotechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gracell Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.